Standard Signal Supplemental Views
The Supplemental Views include the following for each review period (1Month shown here).
Name | Description |
---|---|
All events 1M |
All events reported for the selected drug. |
Closed/dismissed signals 1M |
Events for the selected drug, for which the associated comment or topic state indicates that the signal has been explicitly closed. |
DMEs and TMEs 1M |
All designated medical events and targeted medical events reported for the selected drug. |
New spontaneous cases 1M |
Events reported for the selected drug, for which there have been one or more new spontaneous reports since the last review period. |
New study cases 1M |
Events reported for the selected drug, for which there have been one or more new study reports since the last review period. |
Open/potential signals 1M |
Events reported for the selected drug, for which one of the following is true:
|
Open/potential signals with new cases 1M |
Events reported for the selected drug, with new reports in the last review period for which one of the following is true:
|
Recently reviewed 1M |
Events reported for the selected drug, for which 'Submit Review' action has recently occurred. |
Significant case score 1M |
Events reported for the selected drug with new reports in the last review period for which Period Sum Case Score >= 144 or Cumulative Average Case Score >= 144 |
SMQs and custom terms 1M |
SMQs and custom terms for the selected drug. |
Additionally, Supplemental Views includes one view that is not review-period specific.
Name | Description |
---|---|
Increased frequency |
Listed drug-event combinations with increased frequency of spontaneous reports. |
Parent topic: Data and Scores in Signal Management